BACKGROUND AND OBJECTIVE: Although bcr-abl polymerase chain reaction (PCR)
positivity after bone marrow transplantation (BMT) for chronic myelogenous leukemia (CML) …

Determination of hematological chimerism could be helpful in understanding the biology of
leukemic relapse after allogeneic bone marrow transplant (BMT) for chronic myeloid …

Forty-eight patients treated by allogeneic bone marrow transplantation (BMT) for
Philadelphia (Ph) chromosome-positive chronic myeloid leukemia in chronic phase had …

We read with interest the recent article published in Experimental Hematology by Rieger et
al.[1] entitled,''Mesenchymal Stem Cells Remain of Host Origin Even a Long Time After …

Molecular monitoring of hematopoietic chimerism has become a routine diagnostic
approach in patients after allogeneic stem cell transplantation. Chimerism testing permits the …

We investigated the origin of the fibroblastic compartment of stromal hematopoietic
microenvironment in eight chronic myeloid leukemia (CML) patients following allogeneic …

Serial cytogenetic studies were performed on 64 patients with chronic myelogenous
leukemia (CML) after T cell-depleted allogeneic bone marrow transplantation (BMT). Forty …

In this study we analysed the incidence and clinical impact of the persistence of host
haemopoiesis (mixed chimaerism, MC) after allogeneic BMT in 35 consecutive patients with …

The cytogenetic and clinical course of three patients allografted for Ph positive chronic
myeloid leukaemia are reported. All patients had a peculiar pattern of relapse. Two out of …

We investigated 23 patients for their chimerism status who underwent allogeneic
transplantation using peripheral blood progenitor cells (PBPCT) for chronic myelogenous …